Robert Susman
DirectoratImmunovant· In the 2025 proxy
Robert Susman sits on 1 public board.
Boards1
- ImmunovantDirector · 0 yr on the boardIndependentAudit, Compensation—Paid as an executive
Board seats come from each company's latest proxy statement.
Experience
- ImmunovantPublic company · 1 yr
- Director2025 – Present · 1 yrStock in role -6%
Roles come from the proxy statements of each company.
Activity
Two people shown as one, or a wrong number?